# ENA-001 for Post Operative Respiratory Depression (PORD)

> **NCT06137638** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Enalare Therapeutics Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Respiratory Depression

## Interventions

- **DRUG:** ENA-001

## Key facts

- **NCT ID:** NCT06137638
- **Lead sponsor:** Enalare Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-15
- **Primary completion:** 2027-06-15
- **Final completion:** 2027-07-15
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06137638

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06137638, "ENA-001 for Post Operative Respiratory Depression (PORD)". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT06137638. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*